LUMBAR SPINAL FUSION
Clinical trials for LUMBAR SPINAL FUSION explained in plain language.
Never miss a new study
Get alerted when new LUMBAR SPINAL FUSION trials appear
Sign up with your email to follow new studies for LUMBAR SPINAL FUSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a common anti-inflammatory cut opioid use after spinal fusion?
Symptom relief Recruiting nowThis study tests whether the anti-inflammatory drug ketorolac can lower the amount of strong painkillers (opioids) needed after lumbar spinal fusion surgery. About 140 adults having one- or two-level fusion will receive either ketorolac or a placebo for the first 48 hours after s…
Matched conditions: LUMBAR SPINAL FUSION
Phase: PHASE4 • Sponsor: University of Maryland St. Joseph Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New injection could slash morphine use after spinal fusion
Symptom relief Recruiting nowThis study tests whether a numbing injection called an erector spinae plane block can lower the amount of morphine patients need after lumbar spinal fusion surgery. Researchers will compare morphine use over 72 hours in 130 adults receiving either the block or a placebo. The goal…
Matched conditions: LUMBAR SPINAL FUSION
Phase: NA • Sponsor: Clinique Saint Jean, France • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC